Scientist-Pharmacometrics
Moderna, Inc.
Dr. Sweilem Rihani is a Pharmacometrics Scientist at Moderna, specializing in advancing model-informed drug development, ensuring optimal dose selection, and improving therapeutic outcomes for patients through quantitative pharmacokinetics and pharmacodynamics (PK/PD) modeling. Dr. Rihani has led numerous preclinical and clinical projects in several therapeutic areas including oncology, rare diseases, neurodegenerative diseases, autoimmune, and infectious diseases. He has published over 20 peer-reviewed articles. Dr. Rihani earned his Pharm.D degree from the University of Jordan, a Ph.D. in Pharmaceutical Sciences from Auburn University, Alabama, and a Master's degree in Pharmacometrics from the University of Maryland, Baltimore. Outside of his professional work, he enjoys biking, hiking, and exploring new places.